Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, Hopper JL, Diep A, Bapat B, Salem M, Seminara D, Haile R; Colon Cancer Family Registry.

JAMA. 2005 Feb 16;293(7):799-809.

2.
3.

Mutations predisposing to hereditary nonpolyposis colorectal cancer.

Peltomäki P, de la Chapelle A.

Adv Cancer Res. 1997;71:93-119. Review.

PMID:
9111864
4.

Mutational targets in colorectal cancer cells with microsatellite instability.

Bertholon J, Wang Q, Galmarini CM, Puisieux A.

Fam Cancer. 2006;5(1):29-34. Review.

PMID:
16528606
5.

Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?

Charames GS, Millar AL, Pal T, Narod S, Bapat B.

Hum Genet. 2000 Dec;107(6):623-9. Review.

PMID:
11153917
6.

Cancer risk in mismatch repair gene mutation carriers.

Watson P, Lynch HT.

Fam Cancer. 2001;1(1):57-60. Review.

PMID:
14574017
7.

[Molecular pathology in hereditary colorectal cancer. Recommendations of the Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)].

Rüschoff J, Roggendorf B, Brasch F, Mathiak M, Aust DE, Plaschke J, Mueller W, Poremba C, Kloor M, Keller G, Muders M, Blasenbreu-Vogt S, Rümmele P, Müller A, Büttner R; Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)].

Pathologe. 2004 May;25(3):178-92. Review. German.

PMID:
15138699
8.

Mutator genes and mosaicism in colorectal cancer.

Dunlop MG.

Curr Opin Genet Dev. 1996 Feb;6(1):76-81. Review.

PMID:
8791479
9.

Role of DNA-mismatch repair in anti-neoplastic effects of butyrate.

Dronamraju SS, Coxhead JM, Kelly SB, Mathers JC.

Proc Nutr Soc. 2008 May;67(OCE):E87. doi: 10.1017/S0029665108007192. Review. No abstract available.

PMID:
18768094
10.

Genes and SNPs associated with non-hereditary and hereditary colorectal cancer.

Nassiri M, Kooshyar MM, Roudbar Z, Mahdavi M, Doosti M.

Asian Pac J Cancer Prev. 2013;14(10):5609-14. Review.

11.

Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer.

Jenkins MA, Southey MC, Giles GG, Hopper JL.

Curr Oncol Rep. 2007 May;9(3):202-7. Review.

PMID:
17430691
12.

Colorectal cancer prevention and treatment.

Boland CR, Sinicrope FA, Brenner DE, Carethers JM.

Gastroenterology. 2000 Feb;118(2 Suppl 1):S115-28. Review. No abstract available.

PMID:
10868902
13.

Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer.

Breivik J, Gaudernack G.

Adv Cancer Res. 1999;76:187-212. Review. No abstract available.

PMID:
10218102
14.

Understanding what determines the frequency and pattern of human germline mutations.

Arnheim N, Calabrese P.

Nat Rev Genet. 2009 Jul;10(7):478-88. doi: 10.1038/nrg2529. Review.

15.

Molecular genetics of ovarian cancer.

Shelling AN, Foulkes W.

Mol Biotechnol. 2001 Sep;19(1):13-28. Review.

PMID:
11697218
16.

Inherited mutations in DNA repair genes and cancer risk.

Romero-Laorden N, Castro E.

Curr Probl Cancer. 2017 Jul - Aug;41(4):251-264. doi: 10.1016/j.currproblcancer.2017.02.009. Epub 2017 Mar 22. Review.

PMID:
28454847
17.

The mutation rate and cancer.

Jackson AL, Loeb LA.

Genetics. 1998 Apr;148(4):1483-90. Review.

18.

Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers.

Cox VL, Bhosale P, Varadhachary GR, Wagner-Bartak N, Glitza IC, Gold KA, Atkins JT, Soliman PT, Hong DS, Qayyum A.

Radiology. 2017 May;283(2):314-340. doi: 10.1148/radiol.2017152224. Review.

PMID:
28418819

Supplemental Content

Support Center